Literature DB >> 23892191

The efficacy of the T-shunt procedure and intracavernous tunneling (snake maneuver) for refractory ischemic priapism.

Evangelos Zacharakis1, Amr Abdel Raheem2, Alex Freeman3, Andreas Skolarikos4, Giulio Garaffa2, Andrew N Christopher2, Asif Muneer2, David J Ralph5.   

Abstract

PURPOSE: The current management of ischemic priapism that is refractory to conventional medical therapy is a form of shunt procedure that diverts blood away from the corpus cavernosum. We assessed the outcome of the T-shunt and intracavernous tunneling for the management of ischemic priapism.
MATERIALS AND METHODS: During a 36-month period 45 patients presented with prolonged ischemic priapism. Patients were divided into subgroups according to the duration of priapism. All patients had an unsuccessful primary treatment, and underwent a T-shunt and intracavernous tunneling with cavernous muscle biopsies. All patients completed an IIEF-5 (International Index of Erectile Function-5) questionnaire preoperatively and 6 months postoperatively.
RESULTS: Resolution of the priapism using a T-shunt and snake maneuver occurred in all patients with a priapism duration of less than 24 hours and in only 30% of those with priapism lasting more than 48 hours. After a 6-month median followup the IIEF-5 score was significantly reduced from a mean of 24 (range 23 to 25) preoperatively to 7.7 (range 5 to 24), which was related to the duration of the priapism (p <0.0005). All patients with priapism for more than 48 hours had necrotic cavernous smooth muscle on biopsy and had severe erectile dysfunction requiring the insertion of a penile prosthesis. Those patients with moderate and mild erectile dysfunction were treated with phosphodiesterase type 5 inhibitors.
CONCLUSIONS: The success of the T-shunt with snake tunneling is dependent on the duration of priapism. When it is less than 24 hours the results are favorable, although erectile dysfunction is still present in 50% of patients. In those with a priapism duration greater than 48 hours the technique usually fails to resolve the priapism and all patients end up with erectile dysfunction due to smooth muscle necrosis.
Copyright © 2014 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ED; IIEF-5; International Index of Erectile Function; erectile dysfunction; fibrosis; ischemia; priapism

Mesh:

Year:  2013        PMID: 23892191     DOI: 10.1016/j.juro.2013.07.034

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

1.  How I treat priapism.

Authors:  Uzoma A Anele; Brian V Le; Linda M S Resar; Arthur L Burnett
Journal:  Blood       Date:  2015-03-25       Impact factor: 22.113

Review 2.  Ischaemic priapism: A clinical review.

Authors:  Joanne Ridgley; Nicholas Raison; M Iqbal Sheikh; Prokar Dasgupta; M Shamim Khan; Kamran Ahmed
Journal:  Turk J Urol       Date:  2017-03-01

Review 3.  Review of Ischemic and Non-ischemic Priapism.

Authors:  Mark G Biebel; Martin S Gross; Ricardo Munarriz
Journal:  Curr Urol Rep       Date:  2022-05-10       Impact factor: 3.092

Review 4.  Surgical and minimally invasive treatment of ischaemic and non-ischaemic priapism: a systematic review by the EAU Sexual and Reproductive Health Guidelines panel.

Authors:  S Minhas; A Salonia; U Milenkovic; A Cocci; R Veeratterapillay; K Dimitropoulos; L Boeri; P Capogrosso; N C Cilesiz; M Gul; G Hatzichristodoulou; V Modgil; G I Russo; T Tharakan; M I Omar; C Bettocchi; J Carvalho; Y Yuhong; G Corona; H Jones; A Kadioglu; J I Martinez-Salamanca; P Verze; E C Serefoglu
Journal:  Int J Impot Res       Date:  2022-09-23       Impact factor: 2.408

Review 5.  Surgical tips in difficult penile prosthetic surgery: a narrative review.

Authors:  Nicolò Schifano; Paolo Capogrosso; Onur Omer Cakir; Federico Dehò; Giulio Garaffa
Journal:  Int J Impot Res       Date:  2022-10-19       Impact factor: 2.408

Review 6.  Hydroxyurea therapy for priapism prevention and erectile function recovery in sickle cell disease: a case report and review of the literature.

Authors:  Uzoma A Anele; A Kyle Mack; Linda M S Resar; Arthur L Burnett
Journal:  Int Urol Nephrol       Date:  2014-05-14       Impact factor: 2.370

Review 7.  The use of penile prostheses in the management of priapism.

Authors:  Jonathan Moore; Thomas F Whelan; Gavin M Langille
Journal:  Transl Androl Urol       Date:  2017-11

Review 8.  Role of Penile Prosthesis in Priapism: A Review.

Authors:  Amit G Reddy; Laith M Alzweri; Andrew T Gabrielson; Gabriel Leinwand; Wayne J G Hellstrom
Journal:  World J Mens Health       Date:  2018-01       Impact factor: 5.400

Review 9.  Management of refractory ischemic priapism: current perspectives.

Authors:  Marco Capece; Arianna Gillo; Andrea Cocci; Giulio Garaffa; Massimiliano Timpano; Marco Falcone
Journal:  Res Rep Urol       Date:  2017-08-29

Review 10.  Recent advances in the management of priapism.

Authors:  Asif Muneer; Hussain M Alnajjar; David Ralph
Journal:  F1000Res       Date:  2018-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.